Preparation, radiolabeling and cell culture studies of chitosan coated PLGA nanoparticles as a potential cancer diagnostic agent

Basit Öğe Kaydı
dc.authorscopusid56661951100
dc.authorscopusid57197223304
dc.authorscopusid55748265800
dc.contributor.authorEkinci, Meliha
dc.contributor.authorOzturk, A. Alper
dc.contributor.authorIlem-Ozdemir, Derya
dc.date.accessioned2023-01-12T20:15:13Z
dc.date.available2023-01-12T20:15:13Z
dc.date.issued2022
dc.departmentN/A/Departmenten_US
dc.description.abstractUsing the nanoprecipitation process, chitosan coated poly lactic-co-glycolic acid (PLGA) based polymeric nanoparticle formulations of two molecular weights were developed as a possible cancer cell diagnostic agent. Photon correlation spectroscopy was used to measure the particle size, distribution [polydispersity index (PDI)], and zeta potential values of developed nanoparticle formulations. The F1 [low molecular weight PLGA (Resomer (R) RG 503 H)] and F2 [high molecular weight PLGA (Resomer (R) RG 504 H)] formulations were then directly labeled with Technetium-99m ([99mTc]Tc) using stannous salts (chloride) as a reducing agent. The radiochemical purity (RP) and in vitro stability in different mediums of the formulations were assessed using ascending radioactive thin layer chromatography (RTLC) method. The cell incorporation of [99mTc]Tc labeled F1 and F2 formulations, as well as Reduced/Hydrolized [99mTc]NaTcO4 (R/H-[99mTc]NaTcO4) in the MCF-7 (breast cancer cell line) cells, was then assessed. The nanoparticles had a middle size of 408.9 +/- 3.626 nm to 421.3 +/- 7.205 nm, a PDI value of 0.310 +/- 0.055 to 0.330 +/- 0.066, and a positive charge of +70.5 +/- 1.4 mV to +75.5 +/- 3.8 mV, according to the characterization results. F1 and F2 formulations were effectively radiolabeled with [99mTc]Tc, and their RP was found to be over 98% in both cases. When compared to [99mTc]Tc-F1 (45.091 +/- 2.254%) and R/H-[99mTc]NaTcO4 (8.527 +/- 0.426%), the incorporation percentages of [99mTc]Tc-F2 (70.756 +/- 3.537%) were shown to be higher in cancer cell lines (breast cancer cells, MCF-7). According to this research, radiolabeled chitosan coated PLGA nanoparticles ([99mTc]Tc-F2) could be suggested as promising cancer detection formulations. However, further investigations, such as biodistribution studies, should be performed.en_US
dc.identifier.doi10.29228/jrp.254
dc.identifier.endpage1645en_US
dc.identifier.issn2630-6344
dc.identifier.issn2630-6344en_US
dc.identifier.issue6en_US
dc.identifier.scopus2-s2.0-85142203853en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage1636en_US
dc.identifier.urihttps://doi.org/10.29228/jrp.254
dc.identifier.urihttps://hdl.handle.net/11454/78363
dc.identifier.volume26en_US
dc.identifier.wosWOS:000893010600010en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherMarmara Univen_US
dc.relation.ispartofJournal Of Research In Pharmacyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChitosanen_US
dc.subjectPLGAen_US
dc.subjectnanoparticleen_US
dc.subjectdiagnostic nanosystemen_US
dc.subjecttechnetium-99men_US
dc.subjectradiolabelingen_US
dc.subjectcell cultureen_US
dc.subjectDeliveryen_US
dc.subjectNanoprecipitationen_US
dc.titlePreparation, radiolabeling and cell culture studies of chitosan coated PLGA nanoparticles as a potential cancer diagnostic agenten_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu